Abstract
Gallium-68 DOTATATE has been shown to be useful for a wide range of tumors of neuroendocrine origin including carcinoid, pheochromocytomas, pancreatic islet cell tumors, and medullary carcinoma of the thyroid. Combining PET and MR imaging with DOTATE is an excellent modality to evaluate these somatostatin tumors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Suggested Reading
Bader TR, Semelka RC, Chiu VC, Armao DM, Woosley JT. MRI of carcinoid tumors: spectrum of appearances in the gastrointestinal tract and liver. J Magn Reson Imaging. 2001;14(3):261–9.
Levy AD, Sobin LH. From the archives of the AFIP: gastrointestinal carcinoids: imaging features with clinicopathologic comparison. Radiographics. 2007;27(1):237–57.
Mojtahedi A, Thamake S, Tworowska I, Ranganathan D, Delpassand ES. The value of68Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature. Am J Nucl Med Mol Imaging. 2014;4(5):426–34.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Stein, J.R. (2018). Carcinoid Tumor with Gallium DOTATATE. In: PET/MR Imaging . Springer, Cham. https://doi.org/10.1007/978-3-319-65106-4_53
Download citation
DOI: https://doi.org/10.1007/978-3-319-65106-4_53
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65105-7
Online ISBN: 978-3-319-65106-4
eBook Packages: MedicineMedicine (R0)